Skip to main content
MedPathMedPath Home
Clinical Trials/JPRN-jRCTs031220226
JPRN-jRCTs031220226
Recruiting
未知

A clinical study to investigate the intracerebral dynamics of [18F]K-40 in healthy volunteers.

Ichijo Sadamitsu0 sites5 target enrollmentJuly 27, 2022
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Ichijo Sadamitsu
Enrollment
5
Status
Recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 27, 2022
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
Male

Investigators

Sponsor
Ichijo Sadamitsu

Eligibility Criteria

Inclusion Criteria

  • •1\. Males between 20 and 40 years old at the time of obtaining informed consent.
  • •2\. Males who have no history of neuropsychiatric disorders.
  • •3\. Males who have the ability to express a choice in the MacArthur Competence Assessment Tool (MacCAT), and written consents are provided by them
  • •4\. Males who have no current mental disorders without meeting any criteria in SCID\-I /DSM\-IV,DSM\-5, ICD\-10\.

Exclusion Criteria

  • •1\. Males who are taking psychotropic drugs, antidepressant, hypnotic, anxiolytic, antipsychotic.
  • •2\. Males who are taking prescription drugs other than those listed in criteria1 and cannot stop taking them one week prior to the PET examinations.
  • •3\. Males who are known to be hypersensitive to ethanol.
  • •4\. Males who have neurological diseases (neurodegenerative disease, minor cerebral hemorrhage or cerebral infarction).
  • •5\. Males who have history of brain tumor.
  • •6\. Males who have history of epilepsy.
  • •7\. Males who are taking medical treatment for other diseases.
  • •8\. Males who have substance\-related disorders within 6 months except for nicotine and caffeine.
  • •9\. Males who show positive to addiction drugs in urine drug screening.
  • •10\. Males who have a pacemaker or any metal devices in the body.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
Intracerebral Gene therapy in children with Sanfilippo type B syndromeMucopolysaccharidosis III BMedDRA version: 17.0Level: PTClassification code 10056890Term: Mucopolysaccharidosis IIISystem Organ Class: 10010331 - Congenital, familial and genetic disordersTherapeutic area: Body processes [G] - Genetic Phenomena [G05]
EUCTR2012-000856-33-FRInstitut Pasteur
Not yet recruiting
Not Applicable
Pilot study to distinguish between intracerebral hemorrhage and ischemic stroke using a non-invasive acustoscerebrography in combination with established serum biomarkers.I63I61Cerebral infarctionIntracerebral haemorrhage
DRKS00021724ZNN, Klinik für Neurologie Universitätsklinikum Frankfurt a.M.40
Recruiting
Not Applicable
The study to investigate quantitative neurological examinations for diagnosis and staging of diabetic polyneuropathyDiabetic polyneuropathy
JPRN-UMIN000021916Aichi Medical University60
Recruiting
Phase 2
Study of Cyclodxtrin Therapy for Niemann-Pick disease Type Ciemann-Pick disase, type CLysozome disease, cholesterolD052556
JPRN-jRCTs071190008Matsuo Muneaki3
Completed
Not Applicable
The exploratory study about the neurophysiological index which predicts the effect of the methylphenidate hydrochloride in children with AD/HDAttention deficit hyperactivity disorder
JPRN-UMIN000001270niversity of Tokyo Medical School The department of Psychiatry30